Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Knowing when to switch from passive to active strategies can boost returns. This guide outlines practical signals, costs, and risk considerations.
27,240 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
The Nasdaq down from high has created a disciplined buying moment for patient investors. This guide highlights five t...
Occidental Petroleum leads the 2026 performance among three top U.S. energy explorers, with EOG Resources and ConocoP...
Investors are debating whether Microsoft stock is undervalued. This guide breaks down the fundamentals, growth cataly...
Costco crossed the $1,000 mark in early May 2026, prompting fresh debate about selling in May—even for blue-chip equi...
A dramatic intraday surge in Plug Power stock highlighted the day’s market mood. This article unpacks the catalysts b...
AD Mortgage Trust 2026-NQM4 backs 979 loans, with Florida at 25% of the pool as the company expands its national foot...
Meta Platforms delivered a powerful Q1 2026, with revenue surging and AI investment plans outlined, prompting investo...
The market presses higher as investors cling to earnings resilience and policy stability, with AI and defense leading...
Peloton stock popped today as traders weighed potential index moves and improving momentum. This guide breaks down th...
Stocks climbed as heavyweight tech names posted solid results and ceasefire hopes supported risk appetite, sending th...
Ripple advances toward a national bank charter, triggering headlines and trading shifts for XRP. Experts weigh how wh...